Apple Watch Sales Resume After Federal Court Temporarily Reverses Ban

The ban, linked to a patent dispute with medical technology companies, was not intervened by the Biden administration despite connections to Masimo CEO Joe Kiani.

Apple Watch Series 9 and Ultra 2 sales resume after a federal appeals court temporarily reverses a ban on their import and sale in the United States.
The ban was due to a patent dispute with medical technology companies Masimo and Cercacor Laboratories over blood-oxygen analysis technology.
The Biden administration had the power to reverse the ban but chose not to intervene.
Masimo CEO Joe Kiani, a Democratic donor and supporter of Biden, has been linked to the President, raising concerns of a potential conflict of interest.
The temporary stay on the ban is until January 10, during which the court will review Apple's request for a longer pause during the appeals process.